Henrik Stage
Fondateur chez ADCendo ApS
Fortune : 165 307 $ au 30/04/2024
Provenance du réseau au premier degré de Henrik Stage
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 | |
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology ADCendo ApS is a Danish company that is focused on developing antibody-drug conjugates (ADCs) to treat underserved cancers. The company is based in Humlebaek, Denmark. The company completed a series A extension financing round in 2023, which brought its funds to 82 million EUR to advance into clinical development. The investors in the company include Novo Holdings, Ysios Capital, Pontifax Venture Capital, RA Capital Management, HealthCap, and Gilde Healthcare. The company was founded in 2017 by Christoffer Nielsen, Henrik Stage. Michael Pehl has been the CEO of the company since 2021.
9
| Holding Company | Biotechnology | 9 |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors.
6
| Private Company | Pharmaceuticals: Major | 6 |
Ventac Partners A/S
 Ventac Partners A/S Miscellaneous Commercial ServicesCommercial Services Part of Ventac Partners GmbH, Ventac Partners A/S provides life science consulting services. The company is based in Copenhagen, Denmark. The CEO of the Danish company is Mikael Ørum.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Henrik Stage via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Doctorate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| OREXO AB | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| University of London | College/University | Graduate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| University of Aarhus | College/University | Doctorate Degree Doctorate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Technical University of Denmark | College/University | Graduate Degree | |
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Copenhagen | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Founder Founder | |
Coegin Pharma AS
 Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Pharmaceuticals: Major | Chief Executive Officer | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Etexx Biopharmaceuticals | Founder | ||
Lifandis AS
 Lifandis AS Internet Software/ServicesTechnology Services Lifandis AS provides access to a wealth of biological samples. It offers data and biological material from the HUNT studies. The company was founded in 2007 and is headquartered in Levanger, Norway. | Internet Software/Services | Chairman | |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Founder | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Regenesance BV
 Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | Drugstore Chains | Director/Board Member Founder | |
| Ventac Partners LLC | Corporate Officer/Principal Founder | ||
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| Vingmed Danmark A/S | Corporate Officer/Principal | ||
| IDOGEN AB (PUBL) | Biotechnology | Founder Director/Board Member | |
Neuroscience Technologies SLP
 Neuroscience Technologies SLP Medical/Nursing ServicesHealth Services Neuroscience Technologies SLP provides medical research and laboratory services for neurosciences. The private company is based in Barcelona, ES and has subsidiaries in United Kingdom. The CEO of the Spanish company is Neil Thomas. | Medical/Nursing Services | Chairman | |
Neurescue ApS
 Neurescue ApS Medical SpecialtiesHealth Technology Neurescue ApS develops innovative medical devices for the treatment of cardiac arrest. It offers new platform of treatment methods for paramedics, nurses and doctors alike. The company was founded by Habib Frost in 2013 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Chairman | |
| Neuroscience Technologies Ltd. | Chairman | ||
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| Corporate Culture ApS | Corporate Officer/Principal | ||
| Quantass ApS | Corporate Officer/Principal | ||
Mindway AI ApS
 Mindway AI ApS Information Technology ServicesTechnology Services Mindway AI ApS operates as a software company, which engages in the development of technical solutions for gambling purposes. Its artificial intelligence system works with betting operators, platform providers, regulators, and governments to apply early detection and intervention for safer gambling and gaming activities. The company was founded by Kim Mouridsen and is headquartered in Aarhus, Denmark. | Information Technology Services | Chief Executive Officer | |
CPHI-Holding A/S
 CPHI-Holding A/S Miscellaneous Commercial ServicesCommercial Services CPHI-Holding A/S is a Danish company based in Rodovre, Denmark. The CEOs are Michael Østerlund Madsen, Peter Scheuer Jensen. CPHI-Holding develops airport solutions to enhance passenger experience, including security scanner systems, intelligent trolleys, and baggage handling technologies. The private company has a team of over 30 employees. The company was founded in 1999 by Lars Hojgaard Thogersen, Søren Jakobsen, Rasmus Halfdan Breck. | Miscellaneous Commercial Services | Director/Board Member | |
ACT.Global A/S
 ACT.Global A/S Industrial MachineryProducer Manufacturing ACT.Global A/S provides disinfection and air purification solutions. Its product, Premium Purity, reduces the use of toxic chemicals, water, and plastic that are beneficial to sectors such as healthcare, hospitality, food processing, and beverages. The company was founded by Carsten Jensen in 2013 and is headquartered in Kastrup, Denmark. | Industrial Machinery | Director/Board Member | |
| Perfusion Tech ApS | Director/Board Member | ||
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Go-PEN Aps
 Go-PEN Aps Medical SpecialtiesHealth Technology Go-Pen ApS develops insulin pen. The Danish company was founded in 2019 by Ole Kjerkegaard Nielsen, Michael Ejstrup Hansen. Ole Kjerkegaard Nielsen has been the CEO since 2019. | Medical Specialties | Chairman | |
Rehaler ApS
 Rehaler ApS Medical SpecialtiesHealth Technology Rehaler ApS develops medical devices for the treatment of migraine. | Medical Specialties | Chairman | |
Synklino A/S
 Synklino A/S BiotechnologyHealth Technology Synklino A/S develops a CMV-specific immunotoxin that aims to eliminate cytomegalovirus infections. | Biotechnology | Director/Board Member | |
| TXP Pharma GmbH | Founder Chief Executive Officer Founder Founder Corporate Officer/Principal |
Statistiques
Internationale
| Danemark | 23 |
| Suède | 15 |
| Royaume-Uni | 5 |
| Etats-Unis | 5 |
| Norvège | 3 |
Sectorielle
| Health Technology | 21 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 3 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 145 |
| Corporate Officer/Principal | 55 |
| Chairman | 46 |
| Chief Executive Officer | 45 |
| Founder | 42 |
Relations les plus connectées
| Insiders | |
|---|---|
| Lars Olof Hedbys | 30 |
| Torbjørn Bjerke | 27 |
| Jeppe Øvlesen | 27 |
| Mikael Ørum | 25 |
| Terje Kalland | 20 |
| Thomas Feldthus | 20 |
| Kirsten Drejer | 18 |
| Joël Jean-Mairet | 17 |
| Anders Kronborg | 17 |
| John Sørensen Haurum | 17 |
| Lars Ivar Robert Adlersson | 14 |
| Charlotte Elisabet Edenius | 13 |
| Marina Bozilenko | 13 |
| James Knight | 11 |
| Thomas Boesen | 8 |
- Bourse
- Insiders
- Henrik Stage
- Connexions Sociétés
